Merck hiring risk management physicians
Executive Summary
Merck VP-Risk Management Peter Honig, MD, will hire a Risk Management Group of physicians to assist Merck's drug development teams. Honig will oversee the more than 400 employees that work within Merck's drug safety, postmarketing surveillance and quality assurance divisions. Honig plans to leave his position as FDA Office of Drug Safety director at the end of February to join Merck (1"The Pink Sheet" Jan. 21, p. 21)...
You may also be interested in...
Merck Builds Risk Management Into Drug Development; Hires FDA’s Honi
Merck is building risk management into its product development strategy with the hiring of FDA Office of Drug Safety Director Peter Honig, MD
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.